TNFRSF8 (TNF receptor superfamily member 8)

2003-05-01  

Identity

HGNC
LOCATION
1p36.22
LOCUSID
ALIAS
CD30,D1S166E,Ki-1
FUSION GENES

Other Information

Locus ID:

NCBI: 943
MIM: 153243
HGNC: 11923
Ensembl: ENSG00000120949

Variants:

dbSNP: 943
ClinVar: 943
TCGA: ENSG00000120949
COSMIC: TNFRSF8

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000120949ENST00000263932P28908
ENSG00000120949ENST00000413146P28908
ENSG00000120949ENST00000417814P28908
ENSG00000120949ENST00000514649D6RAG8

Expression (GTEx)

0
10
20
30
40
50
60
70
80
90
100

Pathways

PathwaySourceExternal ID
Cytokine-cytokine receptor interactionKEGGko04060
Cytokine-cytokine receptor interactionKEGGhsa04060
Immune SystemREACTOMER-HSA-168256
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
TNFR2 non-canonical NF-kB pathwayREACTOMER-HSA-5668541
TNFs bind their physiological receptorsREACTOMER-HSA-5669034

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA165948903brentuximab vedotinChemicalLabelAnnotation, Literature, MultilinkAnnotationassociated24433361, 25200691

References

Pubmed IDYearTitleCitations
373772252024Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.0
382116502024CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.1
382131802024Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry.0
382877462024EBV-positive Nodal T-Cell and NK-Cell Lymphoma: A Study of 26 Cases Including a Subset With Strong CD30 Expression Mimicking Anaplastic Large Cell Lymphoma.0
373772252024Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.0
382116502024CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.1
382131802024Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry.0
382877462024EBV-positive Nodal T-Cell and NK-Cell Lymphoma: A Study of 26 Cases Including a Subset With Strong CD30 Expression Mimicking Anaplastic Large Cell Lymphoma.0
359996552023CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.1
371703972023CD30 as a therapeutic target in adult haematological malignancies: Where are we now?3
372909102023CD30 expression in cutaneous B-cell lymphomas.0
376388192023Variant histology of pediatric nodular lymphocyte-predominant Hodgkin lymphoma with IgD and CD30 expression.1
379863462023Differential expression of BCL11b and CDKN2A in CD30-positive peripheral T cell lymphoma: Retrospective study.0
359996552023CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.1
371703972023CD30 as a therapeutic target in adult haematological malignancies: Where are we now?3

Citation

Dessen P

TNFRSF8 (TNF receptor superfamily member 8)

Atlas Genet Cytogenet Oncol Haematol. 2003-05-01

Online version: http://atlasgeneticsoncology.org/gene/42630/tnfrsf8-(tnf-receptor-superfamily-member-8)